Content Loading...
Content Loading...
Product Reference
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
| Author | Jazirehi, Ali R, et al. |
| Citation Information | Cancer Res., 64: 7117-26 (2004), : (2004) |
| Related Products | MAB1501R |
| Pub Med ID | 15466208 |